Amgen Inc. logo

Amgen Inc. (AMG)

Market Closed
4 Jul, 20:00
254. 15
+2.75
+1.09%
- Market Cap
19.61 P/E Ratio
9% Div Yield
31 Volume
18.58 Eps
251.4
Previous Close
Day Range
252.1 254.15
Year Range
230.1 319
Want to track AMG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 30 days

Summary

AMG closed today higher at €254.15, an increase of 1.09% from yesterday's close, completing a monthly increase of 0.24% or €0.6. Over the past 12 months, AMG stock gained 0.18%.
AMG pays dividends to its shareholders, with the most recent payment made on Jun 06, 2025. The next estimated payment will be in In 2 months on Sep 06, 2025 for a total of €2.38.
The last earnings report, released on Apr 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 04, 2025.
Amgen Inc. has completed 4 stock splits, with the recent split occurring on Mar 01, 1999.
The company's stock is traded on 14 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

AMG Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Amgen (AMGN) Outperforms Broader Market: What You Need to Know

Amgen (AMGN) Outperforms Broader Market: What You Need to Know

The latest trading day saw Amgen (AMGN) settling at $296.85, representing a +2.18% change from its previous close.

Zacks | 2 days ago
Trading Rotation Kicks Off 2nd Half of 2025

Trading Rotation Kicks Off 2nd Half of 2025

Tech stocks lagged after a very strong first half of the year, while healthcare led the way.

Zacks | 3 days ago
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know

Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 3 days ago

Amgen Inc. Dividends

Amgen Inc. logo
AMG 10 months ago
Other
€2.25 Per Share
Amgen Inc. logo
AMG 16 May 2024
Other
€2.25 Per Share
Amgen Inc. logo
AMG 15 Feb 2024
Other
€2.25 Per Share
Amgen Inc. logo
AMG 16 Nov 2023
Other
€2.13 Per Share
Amgen Inc. logo
AMG 17 Aug 2023
Other
€2.13 Per Share

Amgen Inc. Earnings

5 Aug 2025 (In 1 month) Date
5.23
Cons. EPS
-
EPS
4 Aug 2025 (In 1 month) Date
-
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
4 Feb 2025 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS
Amgen Inc. logo
AMG 10 months ago
Other
€2.25 Per Share
Amgen Inc. logo
AMG 16 May 2024
Other
€2.25 Per Share
Amgen Inc. logo
AMG 15 Feb 2024
Other
€2.25 Per Share
Amgen Inc. logo
AMG 16 Nov 2023
Other
€2.13 Per Share
Amgen Inc. logo
AMG 17 Aug 2023
Other
€2.13 Per Share
5 Aug 2025 (In 1 month) Date
5.23
Cons. EPS
-
EPS
4 Aug 2025 (In 1 month) Date
-
Cons. EPS
-
EPS
30 Apr 2025 Date
-
Cons. EPS
-
EPS
4 Feb 2025 Date
-
Cons. EPS
-
EPS
30 Oct 2024 Date
-
Cons. EPS
-
EPS

Amgen Inc. (AMG) FAQ

What is the stock price today?

The current price is €254.15.

On which exchange is it traded?

Amgen Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is AMG.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 9%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Aug 04, 2025.

Has Amgen Inc. ever had a stock split?

Amgen Inc. had 4 splits and the recent split was on Mar 01, 1999.

Amgen Inc. Profile

Drug Manufacturers - General Industry
Healthcare Sector
Robert A. Bradway CEO
XFRA Exchange
US0311621009 ISIN
US Country
28,000 Employees
16 May 2025 Last Dividend
22 Nov 1999 Last Split
17 Jun 1983 IPO Date

Overview

Amgen Inc. is a global leader in biotechnology, focusing on the discovery, development, manufacture, and delivery of human therapeutics. The company has a comprehensive portfolio of treatment options targeting various diseases and conditions, ranging from oncology and osteoporosis to cardiovascular diseases and inflammatory disorders. Founded in 1980 and headquartered in Thousand Oaks, California, Amgen serves healthcare providers worldwide, including physicians' clinics, dialysis centers, hospitals, and pharmacies. Its distribution network encompasses pharmaceutical wholesale distributors and direct-to-consumer channels. Amgen’s collaborative efforts extend to several high-profile partnerships with other pharmaceutical giants, including AstraZeneca, Novartis Pharma AG, UCB, Kyowa Kirin Co., Ltd., and BeiGene, Ltd., aiming at the expansion and development of innovative therapies.

Products and Services

  • Enbrel - A leading therapy for plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis.
  • Otezla - Designed for adults suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease.
  • Prolia - Addresses osteoporosis in postmenopausal women.
  • XGEVA - Prevents skeletal-related events.
  • Repatha - Reduces the risk of myocardial infarction, stroke, and coronary revascularization.
  • Nplate - Treats immune thrombocytopenia.
  • KYPROLIS - For relapsed or refractory multiple myeloma patients.
  • Aranesp - Addresses a lower-than-normal number of red blood cells and anemia.
  • EVENITY - A treatment for osteoporosis in postmenopausal for men and women.
  • Vectibix - Treats patients with wild-type RAS metastatic colorectal cancer.
  • BLINCYTO - For patients with acute lymphoblastic leukemia.
  • TEPEZZA - Treats thyroid eye disease.
  • KRYSTEXXA - Addresses chronic refractory gout.
  • Additional Products - Amgen also markets Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA, and PROCYSBI, covering a wide range of therapeutic areas.

Contact Information

Address: One Amgen Center Drive
Phone: 805 447 1000